INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M
Data sources
SEC Form 49m ago
House PTR9m ago
SEC 13F9m ago
Robinhood Chain8m ago

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
PS
Pantelick StevenCHIEF FINANCIAL OFFICER
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$383K
22.2K sh
Aug 12, 2026Aug 14, 2026
Page 505 of 1693
← PrevNext →
traded Aug 12, 2026
+2d
SEC Form 4

Evidence

29
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$141K
3,238 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

29
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$99K
2,273 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

29
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$160K
5,775 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

29
ML
Morettini Joseph LDirector
ASPSALTISOURCE PORTFOLIO SOLUTIONS S.A.
Open-market sale
SELL$1,250
5,000 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

28
NK
Nejatian KasraDirector, Chief Executive Officer
OPENOpendoor Technologies Inc.
Open-market purchase
BUY$100K
27.6K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

28
KM
Kim Sarah MearsDirector
CRSRCorsair Gaming, Inc.
Open-market sale
SELL$121K
8,874 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

28
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$308K
10.5K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

28
TL
Tullis James L LDirector
CRCrane Co
Open-market sale
SELL$138K
614 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

28
DB
Dageville BenoitDirector
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$16.79M
50.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

27
LD
Levingston Lemuel DeonCo-President, Audio Division
UONEKURBAN ONE, INC.
Open-market sale
SELL$9,056
1,677 sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

27
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Open-market sale
SELL$945K
15.4K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

26
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$6,666
150 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

26
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$1.01M
35.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

26
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$1.16M
45.0K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

26
JS
Jain SachinChief Operating Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$110
1 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

26
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$14K
304 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

26
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Option exercise
M$1.93M
78.7K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

26
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Tax withholding
F$8.43M
139.8K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

25
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$147K
5,423 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

25
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$67K
2,375 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

24
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$9.24M
31.6K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

24
KJ
King Mark JamesDirector, Exec Chairman & Interim CEO
JACKJACK IN THE BOX INC
Open-market sale
SELL$105K
5,647 sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

24
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Tax withholding
F$122K
120.5K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

23
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$745K
29.9K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

23
LD
Levingston Lemuel DeonCo-President, Audio Division
UONEKURBAN ONE, INC.
Open-market sale
SELL$475
88 sh
Aug 10, 2026Aug 14, 2026
traded Aug 10, 2026
+4dSEC Form 4

Evidence

23
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$316K
6,138 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

23
FA
Feldman AssafDirector, Chief Strategy Officer - Tech, 10% Owner
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$2.70M
450.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

22
HA
Hoffman AlisonPresident of Starz Networks
STRZSTARZ ENTERTAINMENT CORP /CN/
Open-market sale
SELL$27K
1,036 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

22
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$17K
390 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

22
HA
Hoffman AlisonPresident of Starz Networks
STRZSTARZ ENTERTAINMENT CORP /CN/
Open-market sale
SELL$10K
400 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

22
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Option exercise
M$1.98M
74.7K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

22
KM
Kalish MatthewDirector
DKNGDraftKings Inc.
Option exercise
M$1.80M
383.5K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

22
FJ
Fox-Geen JeremyChief Financial Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$636K
8,476 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

22
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Option exercise
M$1.68M
57.1K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

21
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
7,500 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

21
AC
Androski ChristopherChief Accounting Officer
WHWYNDHAM HOTELS & RESORTS, INC.
Grant or award
A—
3,647 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

21
GE
Gilliam Joseph EDirector
CAICaris Life Sciences, Inc.
Grant or award
A—
13.2K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

21
ML
Morettini Joseph LDirector
ASPSALTISOURCE PORTFOLIO SOLUTIONS S.A.
Open-market sale
SELL$415
1,100 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

21
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
5,781 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence